Department of Medicine and Aged Care, @AgeMelbourne, The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.
Department of Medicine and Community Care, The Royal Melbourne Hospital, Parkville, VIC, Australia.
J Am Med Dir Assoc. 2021 Jun;22(6):1331.e1-1331.e9. doi: 10.1016/j.jamda.2020.09.034. Epub 2020 Nov 6.
To evaluate the effect of Hospital Admission Risk Program (HARP) on unplanned hospitalization, bed days, and mortality of enrolled individuals and to evaluate the cost-effectiveness of HARP.
A retrospective longitudinal analysis of hospital administrative data.
Individuals at risk of hospitalization were provided with multidisciplinary, community-based care support managed by care coordinators including integrated care planning, education, monitoring, service linkages, and general practitioner liaison over 6-9 months.
Individuals who were enrolled into 1 of 8 HARP chronic disease management programs between July 1, 2017, and June 30, 2018, at the Royal Melbourne Hospital, Australia.
Hospital admissions between 18 months before and 18 months after HARP enrollment were analyzed. Total hospital costs were compared between 18 months before and 12 months after HARP enrollment.
A total of 1553 individuals with a median age of 71 years (interquartile range 60-81), 63.4% males, were admitted to HARP. Both unplanned hospitalizations and bed days were reduced during the HARP intervention compared to within 3 months before enrollment in each of the HARP management programs. After the HARP intervention, cardiac coach, cardiac heart failure, chronic respiratory, diabetes comanagement, and medication management programs had higher hospitalizations and bed days than individuals' baseline of at least 3 months before HARP enrollment. Individuals in cardiac heart failure and chronic respiratory management programs had a higher mortality rate than other HARP chronic disease management programs. Individuals in cardiac coach, diabetes comanagement, and medication management programs had lower hospital costs during the HARP intervention compared to within 3 months before HARP enrollment.
HARP reduced unplanned hospitalization and bed days but did not return individuals' hospital use to baseline before the intervention. The variations in mortality between HARP chronic disease management programs implies that condition-specific goals between programs is preferable.
评估医院入院风险计划(HARP)对纳入个体的非计划性住院、住院天数和死亡率的影响,并评估 HARP 的成本效益。
对医院管理数据进行回顾性纵向分析。
有住院风险的个体接受多学科、以社区为基础的护理支持,由护理协调员管理,包括综合护理计划、教育、监测、服务联系以及全科医生联络,持续 6-9 个月。
2017 年 7 月 1 日至 2018 年 6 月 30 日期间,澳大利亚皇家墨尔本医院参加 8 个 HARP 慢性病管理项目之一的个体。
分析 HARP 登记前 18 个月和登记后 18 个月的住院情况。比较 HARP 登记前 18 个月和登记后 12 个月的总住院费用。
共有 1553 名中位年龄 71 岁(四分位距 60-81)、63.4%为男性的个体参加了 HARP。与 HARP 管理项目中的每一个登记前 3 个月相比,HARP 干预期间非计划性住院和住院天数均减少。在 HARP 干预后,心脏教练、心脏心力衰竭、慢性呼吸、糖尿病共管和药物管理项目的住院和住院天数高于个体在 HARP 登记前至少 3 个月的基线。心脏心力衰竭和慢性呼吸管理项目的个体死亡率高于其他 HARP 慢性病管理项目。在 HARP 干预期间,心脏教练、糖尿病共管和药物管理项目的个体住院费用较低,而在 HARP 登记前 3 个月内。
HARP 减少了非计划性住院和住院天数,但没有使个体在干预前的住院使用恢复到基线。HARP 慢性病管理项目之间的死亡率差异表明,项目之间的具体疾病目标更可取。